A carregar...
Long-Term Follow-Up in Cancer Prevention Trials (It Ain’t Over ‘Til It’s Over)
The update of the Study of Tamoxifen and Raloxifene (STAR) by Vogel et al. (beginning on p. XXX in this issue of the journal) highlights the overall importance of long-term follow-up of cancer prevention trials, which need long follow-up to fully determine agent risks and benefits. Biomarkers (e.g.,...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2883740/ https://ncbi.nlm.nih.gov/pubmed/20522799 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-10-0096 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|